You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 46 No. 10, October 1989 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (144)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Risk Factors for Neuroleptic Malignant Syndrome

A Case-Control Study

Paul E. Keck, Jr, MD; Harrison G. Pope, Jr, MD; Bruce M. Cohen, MD, PhD; Susan L. McElroy, MD; Andrew A. Nierenberg, MD

Arch Gen Psychiatry. 1989;46(10):914-918.


Abstract



• A number of risk factors have been proposed for the development of neuroleptic malignant syndrome, but these have not been subjected to controlled study. To address this problem, we performed a case-control study comparing 18 patients with neuroleptic malignant syndrome and 36 matched neuroleptictreated control patients with no known history of the syndrome to identify potential risk factors. Patients with neuroleptic malignant syndrome displayed significantly greater psychomotor agitation, received significantly higher doses of neuroleptics at greater rates of dosage increase, and received a greater number of intramuscular injections than controls.



Author Affiliations



From the Biological Psychiatry Laboratory and Clinical Research Center, Laboratories for Psychiatric Research, Mailman Research Center, McLean Hospital, Belmont, Mass, and Harvard Medical School, Boston, Mass.


Footnotes



Accepted for publication February 13, 1989.

Presented at the 27th Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 13, 1988.

Reprint requests to McLean Hospital, 115 Mill St, Belmont, MA 02178 (Dr Keck).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuroleptic Malignant Syndrome Versus Serotonin Syndrome: The Search for a Diagnostic Tool
Sokoro et al.
The Annals of Pharmacotherapy 2011;45:e50-e50.
ABSTRACT | FULL TEXT  

Neuroleptic Malignant Syndrome: A Review for Neurohospitalists
Berman
The Neurohospitalist 2011;1:41-47.
ABSTRACT | FULL TEXT  

Neuroleptic malignant syndrome: a neuroimmunologic hypothesis
Anglin et al.
CMAJ 2010;182:E834-E838.
FULL TEXT  

Use of psychotropic medication in seven English psychiatric intensive care units
Brown et al.
The Psychiatrist 2010;34:130-135.
ABSTRACT | FULL TEXT  

Acute Dystonic Reaction and the Neuroleptic Malignant Syndrome
White
Journal of Pharmacy Practice 2005;18:175-187.
ABSTRACT  

A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia
Breier et al.
Arch Gen Psychiatry 2002;59:441-448.
ABSTRACT | FULL TEXT  

Neuroleptic malignant syndrome
Adnet et al.
Br J Anaesth 2000;85:129-135.
FULL TEXT  

Neuroleptic Withdrawal in Schizophrenic Patients: A Review of the Literature
Gilbert et al.
Arch Gen Psychiatry 1995;52:173-188.
ABSTRACT  

The Clinical Significance of Serial Creatine Phosphokinase Estimations in Acute Ward Admissions
Wilhelm et al.
Aust N Z J Psychiatry 1994;28:453-457.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.